On The Fly
| ShowHide Related Items >><< - 09/12/22
- Voya Financial appoints My Chi To as chief legal officer
- 08/08/22
- Voya Financial CFO Smith to leave company
- 08/02/22
- Voya Investment Management to acquire Czech Asset Management, no terms
- 07/07/22
- Voya Financial names Heather Lavallee CEO
- 09/20/22
- U.S. video game spending declined 5% year-over-year to $4.1B, says NPD
- 09/12/22
- Netflix to partner with Ubisoft on three exclusive mobile games
- 09/06/22
- Ubisoft board authorizes Tencent to boost stake to 9.99% from 4.5%
- 09/01/22
- Ubisoft confirms 'Assassin's Creed Mirage' title
- 06/13/22
- uCloudlink expands partnership with Ctrip
- 05/20/22
- Senmiao Technology announces agreement with Trip.com Group affiliate
- 05/11/22
- DCT Abu Dhabi enters strategic partnership with Trip.com Group
- 09/15/22
- Adyen partners with Cash App to offer Cash App Pay
- 09/15/22
- CFPB says to make sure 'Buy Now, Pay Later' stays 'fair, transparent'
- 09/15/22
- Shares of Affirm and Block slip after Reuters report of CFPB regulating BNPL
- 09/14/22
- Cathie Wood's ARK Investment bought 101K shares of Block today
- 09/19/22
- Vaccine makers drop after Biden says Covid pandemic is over
- 09/16/22
- Novavax Nuvaxovid receives expanded EUA in Taiwan for ages 12-17
- 09/16/22
- Novavax' Nuvaxovid now available in Israel for ages 12+
- 09/13/22
- Novavax, SII announce registration in South Africa of NVX-CoV2373
- 08/25/22
- NIKE executive joins Dutch Bros board of directors
- 07/27/22
- CarGurus appoints Javier Zamora as general counsel
- 07/19/22
- Skechers down 4% as short-seller Spruce Point sees 30%-50% downside risk
- 06/27/22
- Nike says taking 'cautious approach' to greater China in FY23
- 09/20/22
- Monday.com opens North American headquarters in NYC
- 05/16/22
- Tiger Global buys Starry, exits Adobe in Q1
- 03/28/22
- Cathie Wood's ARK Investment bought 43.6K shares of Monday.com today
- 09/13/22
- IBM sees pretax pension settlement charge of roughly $5.9B in Q3
- 09/08/22
- MetLife appoints Ben Cushman as head of global regulatory policy
- 05/04/22
- MetLife board approves new $3B share repurchase program
- 04/26/22
- MetLife raises quarterly dividend by 4.2% to 50c per share
- 09/21/22
- Eli Lilly says FDA approves Retevmo
- 09/08/22
- Eli Lilly announces new data on Phase 3 study on lebrikizumab
- 09/07/22
- Eli Lilly to present data from studies of Verzenio and Retevmo at ESMO
- 08/25/22
- Aclaris Therapeutics announce patent license agreement with Eli Lilly
- 08/08/22
- Luminaris on track to meet or beat 2022 business milestones
- 06/28/22
- Group of 34 companies ask California Governor to allow autonomous trucks
- 05/25/22
- Luminar hires CJ Moore from Apple, Taner Ozcelik for technical team
- 05/25/22
- Luminar up 4% to $8.80 after Bloomberg report of Apple hire
- 09/01/22
- FTC says Intuit's Credit Karma to pay $3M, halt 'deceptive claims'
- 08/23/22
- Intuit raises LT Small Business and Self-employed revenue growth view to 15%-20%
- 08/16/22
- DigitalOcean says customer email addresses exposed in Mailchimp hack
- 08/15/22
- Third Point adds Disney, exits Intuit in Q2
- 09/08/22
- DocuSign jumps 17% to $67.90 after Q2 earnings beat and guidance
- 08/15/22
- Tiger Global buys Alphabet Class A, exits Zoom Video in Q2
- 06/21/22
- DocuSign CEO Dan Springer to step down, Mary Agnes Wilderotter named interim CEO
- 06/09/22
- DocuSign reports Q1 subscription revenue $569.3M, up 26% y/y
- 09/14/22
- Alcoa falls -9.3%
- 09/08/22
- Alcoa receives certification from the ASI
- 08/28/22
- Fly Intel: Top five weekend stock stories
- 08/22/22
- Strike commences at Alcoa's Mosjoen smelter in Norway
- 09/22/22 UBS
- UBS upgrades Eli Lilly to Buy, says most attractive in big pharma
- 09/14/22 Piper Sandler
- Piper 'surprised' by negative Altimmune reaction after pemvidutide's 'big win'
- 09/13/22 Truist
- Concert Pharmaceuticals price target raised to $25 from $22 at Truist
- 09/06/22 Morgan Stanley
- Biogen named a 'Catalyst Driven Idea' at Morgan Stanley
- 09/22/22 Daiwa
- Trip.com Group upgraded to Buy from Hold at Daiwa
- 09/16/22 UBS
- Trip.com Group initiated with a Neutral at UBS
- 09/13/22 Goldman Sachs
- Trip.com valuation 'more reasonable' after de-rating, says Goldman Sachs
- 09/13/22 Goldman Sachs
- Tongcheng Travel upgraded to Buy from Neutral at Goldman Sachs
- 09/22/22 Citi
- QinetiQ upgraded to Buy from Neutral at Citi
- 08/09/22 JPMorgan
- QinetiQ price target raised to 375 GBp from 355 GBp at JPMorgan
- 05/31/22 Citi
- QinetiQ price target raised to 400 GBp from 382 GBp at Citi
- 05/20/22 Morgan Stanley
- QinetiQ price target raised to 361 GBp from 331 GBp at Morgan Stanley
- 09/22/22 Societe Generale
- Enagas upgraded to Buy from Hold at Societe Generale
- 07/20/22 RBC Capital
- Enagas price target lowered to EUR 16 from EUR 16.50 at RBC Capital
- 07/13/22 Barclays
- Enagas price target lowered to EUR 17.80 from EUR 18.20 at Barclays
- 07/13/22 Exane BNP Paribas
- Enagas downgraded to Underperform from Neutral at Exane BNP Paribas
- 09/22/22 Scotiabank
- Boston Properties upgraded to Outperform from Sector Perform at Scotiabank
- 09/22/22 Evercore ISI
- Boston Properties upgraded to Outperform from In Line at Evercore ISI
- 09/22/22 Scotiabank
- Boston Properties upgraded to Outperform from Sector Perform at Scotiabank
- 09/15/22 Piper Sandler
- Boston Properties price target lowered to $90 from $100 at Piper Sandler
- 09/22/22 Mizuho
- Block downgraded to Neutral from Buy at Mizuho
- 09/21/22 Wedbush
- Wedbush starts Marqeta at Neutral with $8 price target
- 09/21/22 SMBC Nikko
- SMBC Nikko downgrades Block to Neutral into 'prolonged crypto winter'
- 09/21/22 SMBC Nikko
- Block downgraded to Neutral from Outperform at SMBC Nikko
- 09/22/22 Northland
- Luminar downgraded to Market Perform from Outperform at Northland
- 09/20/22 JPMorgan
- Luminar initiated with an Overweight at JPMorgan
- 08/10/22 R.F. Lafferty
- Luminar price target lowered to $24 from $37 at R.F. Lafferty
- 08/10/22 Baird
- Luminar price target lowered to $15 from $30 at Baird
- 09/22/22 Wolfe Research
- Alcoa downgraded to Peer Perform from Outperform at Wolfe Research
- 09/21/22 Credit Suisse
- Alcoa price target lowered to $50 from $63 at Credit Suisse
- 09/16/22 Morgan Stanley
- Alcoa upgraded to Overweight from Equal Weight at Morgan Stanley
- 07/25/22 Morgan Stanley
- Alcoa price target lowered to $51 from $55 at Morgan Stanley
- 09/22/22 JPMorgan
- Novavax downgraded to Underweight from Neutral at JPMorgan
- 08/10/22 B. Riley
- Novavax price target lowered to $126 from $171 at B. Riley
- 08/09/22 TD Cowen
- Novavax price target lowered to $110 from $150 at Cowen
- 07/22/22 B. Riley
- Novavax price target lowered to $171 from $181 at B. Riley
- 09/22/22 Stifel
- Ubisoft downgraded to Hold from Buy at Stifel
- 09/16/22 Barclays
- Ubisoft price target raised to EUR 40 from EUR 38 at Barclays
- 09/07/22 Benchmark
- Tencent investment 'not a big deal' for Ubisoft, says Benchmark
- 08/10/22 Morgan Stanley
- Ubisoft price target lowered to EUR 57 from EUR 59 at Morgan Stanley
- 09/22/22 Morgan Stanley
- Morgan Stanley trims Nike target, says Q1 earnings 'unlikely to move needle'
- 09/22/22 RBC Capital
- Nike initiated with an Outperform at RBC Capital
- 09/21/22 Deutsche Bank
- Nike price target lowered to $123 from $130 at Deutsche Bank
- 09/21/22 Citi
- Citi drops Nike target after survey suggests higher promotions
- 09/22/22 MoffettNathanson
- Intuit initiated with an Outperform at MoffettNathanson
- 09/19/22 CICC
- Intuit initiated with a Market Perform at CICC
- 09/01/22 Citi
- Intuit initiated with a Buy at Citi
- 08/24/22 Evercore ISI
- Intuit price target raised to $601 from $500 at Evercore ISI
- 09/22/22 MoffettNathanson
- DocuSign initiated with an Underperform at MoffettNathanson
- 09/09/22 Wedbush
- DocuSign price target raised to $55 from $50 at Wedbush
- 09/09/22 Baird
- DocuSign price target raised to $70 from $60 at Baird
- 09/09/22 JPMorgan
- DocuSign assumed with Neutral from Underweight at JPMorgan
- 09/22/22 MoffettNathanson
- Monday.com initiated with an Outperform at MoffettNathanson
- 09/12/22 Loop Capital
- Monday.com initiated with a Buy at Loop Capital
- 09/01/22 Citi
- Monday.com initiated with a Buy at Citi
- 08/09/22 DA Davidson
- Monday.com price target raised to $175 from $145 at DA Davidson
- 09/22/22 Raymond James
- MetLife initiated with a Market Perform at Raymond James
- 09/08/22 Jefferies
- Prudential price target raised to $79 from $78 at Jefferies
- 08/22/22 Credit Suisse
- MetLife price target raised to $77 from $68 at Credit Suisse
- 07/13/22 Barclays
- MetLife price target lowered to $75 from $79 at Barclays
- 09/22/22 Raymond James
- Voya Financial initiated with a Strong Buy at Raymond James
- 09/21/22 Raymond James
- Voya Financial initiated with a Strong Buy at Raymond James
- 09/08/22 Jefferies
- Voya Financial price target raised to $68 from $66 at Jefferies
- 09/08/22 Jefferies
- MetLife price target raised to $74 from $72 at Jefferies
- 09/22/22 MoffettNathanson
- LegalZoom initiated with an Underperform at MoffettNathanson
- 09/21/22 Morgan Stanley
- LegalZoom price target lowered to $7 from $9 at Morgan Stanley
- 09/06/22 JMP Securities
- LegalZoom downgraded to Market Perform from Outperform at JMP Securities
- 08/12/22 Credit Suisse
- LegalZoom price target lowered to $19 from $24 at Credit Suisse
- 08/02/22
- Voya Financial reports Q2 adjusted EPS $1.67, consensus $1.28
- 05/03/22
- Voya Financial reports Q1 adjusted EPS $1.47, consensus $1.44
- 05/03/22
- Notable companies reporting after market close
- 07/21/22
- Ubisoft sees Q2 net bookings EUR 270M, confirms 2022 income target
- 07/21/22
- Ubisoft reports Q1 sales EUR 318.2M, down 9.8% vs. last year
- 05/11/22
- Ubisoft sees Q1 net bookings EUR280M
- 05/11/22
- Ubisoft sees FY23 non-IFRS operating income around EUR400M
- 09/21/22
- Trip.com Group reports Q2 adjusted EBITDA RMB 355M, up 290% y/y
- 06/28/22
- Trip.com Group reports Q1 EPS (1c), consensus (1c)
- 08/04/22
- Block reports Q2 adjusted EPS 18c, consensus 16c
- 08/04/22
- Notable companies reporting after market close
- 05/05/22
- Block reports Q1 adjusted EPS 18c, consensus 21c
- 05/05/22
- Notable companies reporting after market close
- 08/08/22
- Novavax cuts FY22 revenue view to $2B-$2.3B from $4B-$5B, consensus $4.27B
- 08/08/22
- Novavax revised FY22 revenue guidance to $2B-$2.3B
- 08/08/22
- Novavax reports Q2 EPS ($6.53) vs. ($4.75) last year
- 05/09/22
- Novavax backs FY22 revenue view $4B-$5B, consensus $4.49B
- 06/27/22
- Nike sees Q1 revenue growth flat to slightly up sequentially, consensus $12.88B
- 06/27/22
- Nike sees FY23 revenue growth in low double digits, consensus $51.57B
- 06/27/22
- Nike reports Q4 EPS 90c, consensus 81c
- 06/27/22
- Notable companies reporting after market close
- 08/08/22
- Monday.com sees Q3 revenue $130M-$131M, consensus $125.74M
- 08/08/22
- Monday.com reports Q2 EPS (33c), consensus (75c)
- 05/16/22
- Monday.com raises FY22 revenue view to $488M-$492M from $470M-$475M
- 05/16/22
- Monday.com sees Q2 revenue $117M-$119M, consensus $110.88M
- 08/03/22
- MetLife reports Q2 adjusted EPS $2.00, consensus $1.45
- 08/03/22
- Notable companies reporting after market close
- 05/04/22
- MetLife reports Q1 adjusted EPS $2.08, consensus $1.65
- 05/04/22
- Notable companies reporting after market close
- 08/11/22
- LegalZoom cuts FY22 revenue view to $612M-$616M from $650-$660M
- 08/11/22
- LegalZoom sees Q3 revenue $149M-$151M, consensus $171.21M
- 08/11/22
- LegalZoom reports Q2 EPS 5c, consensus 2c
- 05/12/22
- LegalZoom sees Q2 revenue $162M-$164M, consensus $165.08M
- 08/04/22
- Eli Lilly cuts FY22 EPS view to $7.90-$8.05 from $8.15-$8.30, consensus $8.08
- 08/04/22
- Eli Lilly reports Q2 EPS $1.25, consensus $1.68
- 08/03/22
- Notable companies reporting before tomorrow's open
- 08/08/22
- Luminar reports Q2 adjusted EPS (18c), consensus (16c)
- 08/08/22
- Notable companies reporting after market close
- 05/05/22
- Luminar reports Q1 EPS (25c), consensus (13c)
- 08/23/22
- Intuit sees FY23 adjusted EPS $13.59-$13.89, consensus $13.81
- 08/23/22
- Intuit sees Q1 adjusted EPS $1.14-$1.20, consensus $1.86
- 08/23/22
- Intuit reports Q4 adjusted EPS $1.10, consensus 98c
- 08/23/22
- Notable companies reporting after market close
- 09/08/22
- DocuSign sees FY23 revenue $2.47B-$2.48B, consensus $2.47B
- 09/08/22
- DocuSign sees Q3 revenue $624M-$628M, consensus $625.05M
- 09/08/22
- DocuSign reports Q2 non-GAAP EPS 44c, consensus 42c
- 09/08/22
- Notable companies reporting after market close
- 07/26/22
- Boston Properties sees Q3 FFO $1.86-$1.88, consensus $1.89
- 07/26/22
- Boston Properties reports Q2 FFO $1.94, consensus $1.85
- 05/02/22
- Boston Properties sees FY22 FFO $7.40-$7.50, consensus $7.40
- 05/02/22
- Boston Properties sees Q2 FFO $1.84-$1.86, consensus $1.83
- 07/20/22
- Alcoa reports Q2 adjusted EPS $2.67, consensus $2.31
- 07/20/22
- Notable companies reporting after market close
- 04/20/22
- Alcoa reports Q1 EPS $3.06, consensus $2.93
- 04/20/22
- Notable companies reporting after market close
|